M W Brechbiel

An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer.

Michael R. McDevitt, E Barendswaard, Dangshe Ma et al. · PubMed · 2000 · 258 citations

Medicine, Nuclear Medicine, Oncology +17

Nature of the bifunctional chelating agent used for radioimmunotherapy with yttrium-90 monoclonal antibodies: critical factors in determining in vivo survival and organ toxicity.

Robert W. Kozak, Andrew Raubitschek, Saed Mirzadeh et al. · PubMed · 1989 · 171 citations

Pharmacy, Immunology, Pharmacology +17

Improved in vivo stability and tumor targeting of bismuth-labeled antibody.

Curtis Ruegg, Wendie T. Anderson-Berg, M W Brechbiel et al. · PubMed · 1990 · 131 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16

Tumor targeting and imaging of intraperitoneal tumors by use of antisense oligo-DNA complexed with dendrimers and/or avidin in mice.

Noriko Sato, H Kobayashi, Tsuneo Saga et al. · PubMed · 2001 · 112 citations

Pharmacy, Molecular Biology, Oncology +17

PET imaging of (86)Y-labeled anti-Lewis Y monoclonal antibodies in a nude mouse model: comparison between (86)Y and (111)In radiolabels.

Anna Lövqvist, John L. Humm, Arif Sheikh et al. · PubMed · 2001 · 86 citations

Medicine, Nuclear Medicine, Oncology +17